Exane Derivatives’s ASML ASML Stock Holding History

Exane Derivatives’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.2M	Sell	2,521 -880	-26%	-$491K	0.69%	33
2022 Q1	$2.27M	Sell	3,401 -34	-1%	-$22.8K	0.64%	26
2021 Q4	$2.73M	Buy	3,435 +2,258	+192%	+$1.79M	0.66%	23
2021 Q3	$877K	Buy	1,177 +594	+102%	+$467K	0.21%	100
2021 Q2	$412K	Buy	+583	New	+$385K	0.09%	229
2020 Q1	–	Sell	-6,928	Closed	-$2.08M	–	704
2019 Q4	$2.08M	Buy	+6,928	New	+$1.87M	0.39%	84

Other funds holding ASML

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Exane Derivatives's ASML Position: Q2 2022 in Review

Exane Derivatives reduced its ASML (ASML) stake by 26% in Q2 2022, selling an estimated $491K and leaving 2,521 shares worth $1.2M. The position accounts for 0.69% of the portfolio, ranked #33.

Exane Derivatives first reported a position in ASML in Q4 2019 and has held it in 6 quarters since. The position peaked at $2.73M in Q4 2021. 922 funds tracked by Wall St. Rank hold ASML as of Q2 2022.

Exane Derivatives held 2,521 shares of ASML worth $1.2M as of Q2 2022.
Exane Derivatives sold 880 ASML shares in Q2 2022, an estimated $491K.
ASML made up 0.69% of Exane Derivatives's portfolio in Q2 2022, its #33 holding.
Exane Derivatives first reported a position in ASML in Q4 2019 and has held it in 6 quarters since.
Exane Derivatives's ASML position peaked at $2.73M in Q4 2021.
922 funds tracked by Wall St. Rank held ASML as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.